MAPRE1 and central nervous system cancer: We transfected U251 human glioma cells with fluorescently tagged end-binding protein 1 (EB1-eGFP), which labels growing microtubule ends (Figure 1A), and treated them with either DMSO (vehicle), or varying doses (1–100 nM) of either MTA.